Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Change in Acquisitions & Divestments: 2017-2024

Historic Change in Acquisitions & Divestments for Editas Medicine (EDIT) over the last 8 years, with Dec 2024 value amounting to $257.2 million.

  • Editas Medicine's Change in Acquisitions & Divestments fell 53.96% to $40.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.5 million, marking a year-over-year decrease of 48.11%. This contributed to the annual value of $257.2 million for FY2024, which is 0.89% down from last year.
  • According to the latest figures from FY2024, Editas Medicine's Change in Acquisitions & Divestments is $257.2 million, which was down 0.89% from $259.5 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Change in Acquisitions & Divestments ranged from a high of $433.4 million in FY2022 and a low of $257.2 million during FY2024.
  • In the last 3 years, Editas Medicine's Change in Acquisitions & Divestments had a median value of $259.5 million in 2023 and averaged $316.7 million.
  • Per our database at Business Quant, Editas Medicine's Change in Acquisitions & Divestments rose by 19.58% in 2022 and then plummeted by 40.12% in 2023.
  • Over the past 5 years, Editas Medicine's Change in Acquisitions & Divestments (Yearly) stood at $305.0 million in 2020, then rose by 18.82% to $362.4 million in 2021, then grew by 19.58% to $433.4 million in 2022, then slumped by 40.12% to $259.5 million in 2023, then fell by 0.89% to $257.2 million in 2024.